Usefulness of lipoprotein changes during acute coronary syndromes for predicting postdischarge lipoprotein levels

被引:26
|
作者
Henkin, Y
Crystal, E
Goldberg, Y
Friger, M
Lorber, J
Zuili, I
Shany, S
机构
[1] Ben Gurion Univ Negev, Soroka Med Ctr, Dept Cardiol, IL-84105 Beer Sheva, Israel
[2] Ben Gurion Univ Negev, Soroka Med Ctr, Dept Epidemiol, IL-84105 Beer Sheva, Israel
[3] Ben Gurion Univ Negev, Soroka Med Ctr, Dept Biochem, IL-84105 Beer Sheva, Israel
[4] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2002年 / 89卷 / 01期
关键词
D O I
10.1016/S0002-9149(01)02154-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of our study was to evaluate the lipoprotein changes that occur during acute coronary events, and to determine the lipoprotein threshold levels that identify patients who require future statin therapy. Lipoprotein levels were measured at admission, at 6 hours, the morning after admission, before discharge, and 3 months after discharge in patients with myocardial infarction and unstable angina. Patients with myocardial infarction on thrombolytic therapy (n = 63) and patients with unstable angina (n = 33) had a decrease in low-density lipoprotein (LDL) cholesterol levels less than or equal to24 hours after admission (-12 +/- 20% and -6 +/- 23%, respectively), but these levels returned to baseline before discharge. In patients with myocardial infarction who did not receive thrombolytic therapy (n = 37), the decrease was more gradual and peaked before hospital discharge (-7 +/- 19%). There was good correlation between LDL cholesterol levels at admission and after discharge, especially in normotriglyceridemic patients. Over 90% of patients with LDL cholesterol greater than or equal to125 mg/dl on the morning after admission were candidates for statin therapy after discharge. Thus, the need for future statin therapy can be predicted with fair reliability during the initial 24 hours after admission. However, elevated baseline triglyceride levels significantly affect these LDL cholesterol changes and complicate prediction of long-term lipoprotein levels. (C) 2002 by Excerpta Medica, Inc.
引用
收藏
页码:7 / 11
页数:5
相关论文
共 50 条
  • [1] Lipoprotein changes during acute coronary syndromes
    Batalla, A
    Hevia, S
    Sieres, M
    Raviña, T
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (05): : 572 - 572
  • [2] HIGH DENSITY LIPOPROTEIN LEVELS IN BLACKS PRESENTING WITH ACUTE CORONARY SYNDROMES
    Kemeyou, Line
    Dodani, Sunita
    McCurdy, Kaitlin
    Joseph, Alexandra
    Kraemer, Dale
    Smotherman, Carmen
    Velarde, Gladys P.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A64 - A64
  • [3] GENDER AND RACIAL DIFFERENCES IN HIGH DENSITY LIPOPROTEIN LEVELS IN ACUTE CORONARY SYNDROMES
    Velarde, Gladys Palacio
    Bravo, Katia
    Ozaki, Asuka
    Smotherman, Carmen
    Kraemer, Dale
    Dodani, Sunita
    Joseph, Alexandra
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A95 - A95
  • [4] ELEVATED LEVELS OF OXIDIZED LIPOPROTEIN(A) ARE ASSOCIATED WITH THE PRESENCE AND SEVERITY OF ACUTE CORONARY SYNDROMES
    Wang, J.
    Zhang, C.
    Meng, Y.
    Han, A.
    Gong, J.
    Li, K.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [5] Prognostic Value of Lipoprotein(a) Levels in Patients Undergoing Coronary Angiography for Premature Acute Coronary Syndromes
    Wang, Le
    Cong, Hongliang
    Zhang, Jingxia
    Hu, Yuecheng
    Wei, Ao
    Zhang, Yingyi
    [J]. ANGIOLOGY, 2020, 71 (02) : 160 - 166
  • [6] Lipoprotein (a), Apo (a) phenotypes and dyslipidemia in acute coronary syndromes
    Rohbani-Noubar, M
    Zarghami, N
    Rashtchizadeh, N
    [J]. CLINICA CHIMICA ACTA, 2005, 355 : S102 - S103
  • [8] Lipoprotein(a) is not associated with survival after acute coronary syndromes
    Roth, C.
    Dalos, D.
    Gangl, C.
    Krychtiuk, K.
    Schrutka, L.
    Distelmaier, K.
    Wojta, J.
    Hengstenberg, C.
    Berger, R.
    Speidl, W.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 2790 - 2790
  • [9] Sex and Racial Differences in High-Density Lipoprotein Levels in Acute Coronary Syndromes
    Ozaki, Asuka
    Bravo-Jaimes, Katia
    Smotherman, Carmen
    Kraemer, Dale F.
    Samura, Alfred
    Velarde, Gladys P.
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2021, 362 (05): : 435 - 441
  • [10] Mechanized lipoprotein(a) assay as a marker for coronary artery disease illustrates the usefulness of high lipoprotein(a) levels
    Hobbs, GA
    Kaplan, IV
    Levinson, SS
    [J]. CLINICA CHIMICA ACTA, 1998, 274 (01) : 1 - 13